Carole Henique, Guillaume Bollée, Xavier Loyer, Florian Grahammer, Neeraj Dhaun, Marine Camus, Julien Vernerey, Léa Guyonnet, François Gaillard, Hélène Lazareth, Charlotte Meyer, Imane Bensaada, Luc Legrès, Takashi Satoh, Shizuo Akira, Patrick Bruneval, Stefanie Dimmeler, Alain Tedgui, Alexandre Karras, Eric Thervet, Dominique Nochy, Tobias Huber, Laurent Mesnard, Olivia Lenoir, Pierre-Louis Tharaux
- Crescentic rapidly progressive glomerulonephritis (RPGN) represents the most aggressive form of acquired glomerular disease. While most therapeutic approaches involve potentially toxic immunosuppressive strategies, the pathophysiology remains incompletely understood. Podocytes are glomerular epithelial cells that are normally growth-arrested because of the expression of cyclin-dependent kinase (CDK) inhibitors. An exception is in RPGN where podocytes undergo a deregulation of their differentiated phenotype and proliferate. Here we demonstrate that microRNA-92a (miR-92a) is enriched in podocytes of patients and mice with RPGN. The CDK inhibitor p57Kip2 is a major target of miR-92a that constitutively safeguards podocyte cell cycle quiescence. Podocyte-specific deletion of miR-92a in mice de-repressed the expression of p57Kip2 and prevented glomerular injury in RPGN. Administration of an anti-miR-92a after disease initiation prevented albuminuria and kidney failure, indicating miR-92a inhibition as a potential therapeutic strategy for RPGN. We demonstrate that miRNA induction in epithelial cells can break glomerular tolerance to immune injury.
MetadatenAuthor: | Carole Henique, Guillaume Bollée, Xavier Loyer, Florian GrahammerORCiDGND, Neeraj Dhaun, Marine Camus, Julien Vernerey, Léa Guyonnet, François Gaillard, Hélène Lazareth, Charlotte Meyer, Imane Bensaada, Luc Legrès, Takashi Satoh, Shizuo AkiraGND, Patrick Bruneval, Stefanie DimmelerORCiDGND, Alain Tedgui, Alexandre Karras, Eric Thervet, Dominique Nochy, Tobias HuberORCiDGND, Laurent Mesnard, Olivia Lenoir, Pierre-Louis Tharaux |
---|
URN: | urn:nbn:de:hebis:30:3-467987 |
---|
DOI: | https://doi.org/10.1038/s41467-017-01885-7 |
---|
ISSN: | 2041-1723 |
---|
Pubmed Id: | https://pubmed.ncbi.nlm.nih.gov/29184126 |
---|
Parent Title (English): | Nature Communications |
---|
Publisher: | Nature Publishing Group UK |
---|
Place of publication: | [London] |
---|
Document Type: | Article |
---|
Language: | English |
---|
Year of Completion: | 2017 |
---|
Date of first Publication: | 2017/11/27 |
---|
Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
---|
Release Date: | 2018/09/27 |
---|
Tag: | Glomerular diseases; Mechanisms of disease; Molecular medicine |
---|
Volume: | 8 |
---|
Issue: | 1, Art. 1829 |
---|
Page Number: | 15 |
---|
First Page: | 1 |
---|
Last Page: | 15 |
---|
Note: | Rights and permissions: Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
---|
HeBIS-PPN: | 438423097 |
---|
Institutes: | Medizin / Medizin |
---|
| Exzellenzcluster / Exzellenzcluster Makromolekulare Komplexe |
---|
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
---|
Sammlungen: | Universitätspublikationen |
---|
Licence (German): | Creative Commons - Namensnennung 4.0 |
---|